论文部分内容阅读
目的:观察分析肠胃康颗粒治疗慢性胃炎的临床疗效。方法:选取我院2011年1月至2013年9月在门诊诊治的慢性胃炎患者100例,随机分为对照组和实验组,每组各50例,对照组采用慢性胃炎常规药物治疗,实验组在对照组基础上予口服肠胃康颗粒,比较两组的临床疗效。结果:实验组的临床疗效明显高于对照组,两组比较差异有统计学意义(P<0.05)。结论:慢性胃炎在常规药物治疗基础上加用肠胃康颗粒,可有效提高临床疗效,减轻病情,改善生活质量,值得临床上推广应用。
Objective: To observe and analyze the clinical effect of Changweikang granule in treating chronic gastritis. Methods: One hundred patients with chronic gastritis diagnosed and treated in our hospital from January 2011 to September 2013 were randomly divided into control group and experimental group, with 50 cases in each group. The control group was treated with routine drug treatment of chronic gastritis. The experimental group On the basis of the control group, we took Changweikang Granule orally, and compared the clinical curative effect of the two groups. Results: The clinical efficacy of the experimental group was significantly higher than that of the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion: Chronic gastritis with conventional drug therapy based on the use of Weiweikang particles, which can effectively improve clinical efficacy, reduce disease and improve quality of life, it is worth promoting the clinical application.